A retrospective, interventional, consecutive case series study to evaluate one year outcomes of aflibercept in recurrent or persistent neovascular age-related macular degeneration.
Phase of Trial: Phase IV
Latest Information Update: 05 Dec 2015
At a glance
- Drugs Aflibercept (Primary)
- Indications Age-related macular degeneration
- Focus Therapeutic Use
- 05 Dec 2015 New trial record